Chronic, active Epstein-Barr virus infection
- 1 January 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 7 (1) , 59-63
- https://doi.org/10.1097/00062752-200001000-00011
Abstract
Chronic active Epstein-Barr virus (EBV) infection is an uncommon outcome of EBV infection and may present as a waxing and waning or fulminant syndrome. Unlike acute infectious mononucleosis, wherein EBV establishes lifelong infection and survives by maintaining a delicate balance with the host as a latent infection, in chronic active EBV infection the host-virus balance is disturbed. The mechanisms by which this balance becomes perturbed are likely to be heterogenous and may involve host immune factors, viral factors, or both. A number of subtle immunologic defects have been reported in patients with chronic active EBV infection. Enhanced expression of viral genes has also been noted in some cases. Treatment of chronic active EBV infection has proven difficult, but new modalities including etoposide-based regimens and adoptive transfer of EBV-specific cytotoxic T lymphocytes have shown promise.Keywords
This publication has 31 references indexed in Scilit:
- Anti‐Interleukin‐10 Antibodies in Patients with Chronic Active Epstein‐Barr Virus InfectionThe Journal of Infectious Diseases, 1997
- Human and Viral Interleukin-10 in Acute Epstein-Barr Virus-Induced Infectious MononucleosisThe Journal of Infectious Diseases, 1995
- Defective activity of Epstein‐Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parentsPediatrics International, 1993
- Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.The Journal of Experimental Medicine, 1992
- Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.The Journal of Experimental Medicine, 1992
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991
- Brief report: Killer cell defect and persistent immunological abnormalities in two patients with chronic active epstein‐barr virus infectionJournal of Medical Virology, 1989
- T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus InfectionsNew England Journal of Medicine, 1988
- Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.The Journal of Experimental Medicine, 1980
- Surface Markers on Human B and T LymphocytesScandinavian Journal of Immunology, 1976